Clinical trials recruiting for Prostate Cancer Metastatic Castration-Resistant
3
Recruiting trials
0
US states with sites
3
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 2Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| External Beam Radiotherapy Delivered Between Cycles of Radioligand Radiotherapy | 1 |
| Sacituzumab tirumotecan | 1 |
| Tagitanlimab | 1 |
Self-screener
Recruiting trials
- External Beam and Radioligand Radiotherapy for mCRPC
- Liquid Biopsy Under PSMA Radioligand Therapy
- Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)
Related conditions
Trials recruiting for Prostate Cancer Metastatic Castration-Resistant often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Prostate Cancer Metastatic Castration-Resistant trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.